Strategic Acquisitions IBA Dosimetry has recently expanded its product portfolio and geographical footprint through strategic acquisitions of Radcal, an X-ray imaging specialist, and Modus Medical Devices. These acquisitions suggest opportunities to offer integrated imaging and dosimetry solutions, catering to a broader range of diagnostic and therapeutic needs.

Innovative Tech Launches The company has launched advanced radiation therapy QA platforms like myQA iON and enhanced myQA Machines, showcasing ongoing commitment to technological innovation. This indicates a strong focus on providing cutting-edge solutions that could benefit clinics seeking to upgrade their therapy accuracy and safety systems.

Market Leadership As the world's leading provider in dosimetry installations and innovations, IBA Dosimetry occupies a prime position to upsell comprehensive radiation quality assurance solutions to large hospitals and cancer treatment centers looking for proven, reliable systems.

Growing US Presence With recent acquisitions and a US subsidiary, IBA Dosimetry is strengthening its North American presence, creating potential sales opportunities within the US market, especially among hospitals and radiology clinics seeking advanced dosimetry and imaging integration.

Focus on Safety and Precision The company's emphasis on delivering precise, safe radiation therapy solutions positions it well to target healthcare facilities prioritizing high-quality patient outcomes, offering opportunities for tailored, high-end QA systems to improve treatment accuracy.